By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
It is crucial for the diagnosis and management of glaucoma patients, especially those with severe vision, to have an implantable intraocular pressure sensor that can measure intraocular pressure correctly over an extended period of time and in real time.
Aqueous humour production and drainage by the ciliary body, as well as its passage through the trabecular meshwork and uveoscleral outflow, all affect intraocular pressure. This is due to the posterior segment’s vitreous humour’s relatively stable volume, which has little impact on the management of intraocular pressure.
The Global Eye pressure sensor market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
A German company that develops medical devices has implanted an eye pressure sensor in its first patient with glaucoma, potentially revolutionising how the condition is managed in the future.
The technique is a part of Implantdata’s first-in-human clinical trial to validate the EYEMATE-SC sensor implant, which is located in the eye and is intended to allow continuous monitoring of intraocular pressure (IOP).
The majority of patients having glaucoma surgery are probably qualified candidates for such a pressure sensor because the new Implandata sensor is pleasantly small and simple to surgically implant.
For the first time ever, this ground-breaking tool enables glaucoma patients to continuously track their own ocular pressure.They anticipate that it will increase therapeutic adherence and greatly lower the chance of unneeded vision field loss or perhaps blindness due to glaucoma.
It is the company’s follow-up to the CE-marked EYEMATE-IO intraocular sensor implant, which is utilised on glaucoma patients having cataract surgery.
The remote patient care capabilities of EYEMATE will lead to more effective disease management because a significant percentage of patients’ office visits may be reduced while the eye doctor gains more and better knowledge of the patient’s unique circumstances.
By combining IOP measurement data, researchers may be able to better understand how the condition develops and progresses, which could lead to the development of fresh or more effective intervention strategies.
